PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 213 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $38,000 | +153.3% | 2,100 | 0.0% | 0.01% | +133.3% |
| Q1 2020 | $15,000 | -70.0% | 2,100 | 0.0% | 0.00% | -66.7% |
| Q4 2019 | $50,000 | -10.7% | 2,100 | 0.0% | 0.01% | -18.2% |
| Q3 2019 | $56,000 | -1.8% | 2,100 | 0.0% | 0.01% | -8.3% |
| Q2 2019 | $57,000 | -21.9% | 2,100 | 0.0% | 0.01% | -36.8% |
| Q1 2019 | $73,000 | +78.0% | 2,100 | 0.0% | 0.02% | +72.7% |
| Q4 2018 | $41,000 | -26.8% | 2,100 | 0.0% | 0.01% | -26.7% |
| Q3 2018 | $56,000 | -29.1% | 2,100 | 0.0% | 0.02% | -34.8% |
| Q2 2018 | $79,000 | +21.5% | 2,100 | 0.0% | 0.02% | +21.1% |
| Q1 2018 | $65,000 | -35.6% | 2,100 | 0.0% | 0.02% | -42.4% |
| Q4 2017 | $101,000 | -12.2% | 2,100 | 0.0% | 0.03% | -15.4% |
| Q3 2017 | $115,000 | -8.0% | 2,100 | 0.0% | 0.04% | -18.8% |
| Q2 2017 | $125,000 | – | 2,100 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 232,952 | $5,498,000 | 5.39% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,673,727 | $86,700,000 | 3.41% |
| Redmile Group, LLC | 1,466,537 | $34,610,000 | 3.31% |
| SECTORAL ASSET MANAGEMENT INC | 1,229,382 | $29,013,000 | 3.00% |
| HARVEY CAPITAL MANAGEMENT INC | 206,530 | $4,874,000 | 2.44% |
| Marcus Capital, LLC | 75,150 | $1,774,000 | 1.87% |
| Cormorant Asset Management, LP | 396,000 | $9,346,000 | 1.32% |
| Rail-Splitter Capital Management, LLC | 221,414 | $5,225,000 | 1.25% |
| Temasek Holdings (Private) Ltd | 6,583,568 | $155,372,000 | 1.21% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 636,526 | $15,022,000 | 0.84% |